# Protein kinase a regulates cyclooxygenase-2 expression through the RNA-binding proteins HuR and TTP

**Authors:** Sendi Rafael Adame-Garcia, Thomas S. Hoang, Pham Thuy Tien Vo, Valeria Burghi, Rodolfo Daniel Cervantes-Villagrana, Lennis Beatriz Orduña-Castillo, Dana J. Ramms, JoAnn Trejo, J. Silvio Gutkind

PMC · DOI: 10.1016/j.jbc.2025.111064 · The Journal of Biological Chemistry · 2025-12-18

## TL;DR

This study shows how protein kinase A controls COX-2 expression in macrophages by interacting with RNA-binding proteins HuR and TTP.

## Contribution

Discovers a new posttranscriptional mechanism where PKA regulates COX-2 mRNA stability via HuR and TTP.

## Key findings

- PKA activity is essential for COX-2 expression through posttranscriptional mRNA stabilization.
- PKA interacts with HuR to increase COX-2 mRNA binding and stability.
- PKA phosphorylates TTP, reducing its ability to destabilize COX-2 mRNA.

## Abstract

Cyclooxygenase-2 (COX-2/PTGS2) is an inducible enzyme central to inflammatory responses, and its expression is tightly regulated. Elevated intracellular cAMP levels are known to stimulate COX-2 expression. However, the precise mechanism by which protein kinase A (PKA), the primary cAMP effector, mediates this process remains elusive. In this study, we investigated the role of PKA in regulating COX-2 expression in macrophages. We found that PKA activity is essential for COX-2 expression, primarily through a posttranscriptional mechanism that enhances COX-2 mRNA stability. This effect is mediated by the interaction between PKA and the RNA-binding proteins HuR (ELAVL1) and TTP (tristetraprolin/ZFP36). Specifically, we observed that the catalytic subunit of PKA directly interacts with HuR, Hu antigen R (HuR), a well-established COX-2 mRNA stabilizer. PKA activation increased HuR binding to COX-2 mRNA, and pharmacological inhibition of HuR abrogated COX-2 expression in macrophages stimulated with PGE2 and interleukin-1β. Furthermore, PKA stimulates the phosphorylation of TTP, an mRNA-destabilizing protein, thereby reducing its binding to the COX-2 transcript. We propose that PKA enhances COX-2 expression by interacting with HuR, maintaining proximity to COX-2 mRNA, and protecting it from TTP-mediated destabilization. Our findings reveal a mechanistic link between PKA activity and COX-2 mRNA stability through HuR and TTP, highlighting the role of RNA-binding proteins as novel effectors of PKA signaling in posttranscriptional regulation.

## Linked entities

- **Genes:** COX2 (cytochrome c oxidase subunit II) [NCBI Gene 4513], PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743], ELAVL1 (ELAV like RNA binding protein 1) [NCBI Gene 1994], ELAVL1 (ELAV like RNA binding protein 1) [NCBI Gene 1994], ZFP36 (ZFP36 zinc finger CCCH-type) [NCBI Gene 7538], ZFP36 (ZFP36 zinc finger CCCH-type) [NCBI Gene 7538]
- **Proteins:** ELAVL1 (ELAV like RNA binding protein 1), ZFP36 (ZFP36 zinc finger CCCH-type), COX2 (cytochrome c oxidase subunit II)

## Full-text entities

- **Genes:** ZFP36 (ZFP36 zinc finger CCCH-type) [NCBI Gene 7538] {aka G0S24, GOS24, NUP475, RNF162A, TIS11, TTP}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, COX2 (cytochrome c oxidase subunit II) [NCBI Gene 4513] {aka COII, MTCO2}, ELAVL1 (ELAV like RNA binding protein 1) [NCBI Gene 1994] {aka ELAV1, HUR, Hua, MelG}, PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743] {aka COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2}
- **Diseases:** inflammatory (MESH:D007249)
- **Chemicals:** PGE2 (MESH:D015232), cAMP (-)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12914655/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12914655/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC12914655/full.md

---
Source: https://tomesphere.com/paper/PMC12914655